User:Mr. Ibrahem/Beractant

Beractant, sold under the brand name Survanta, is a medication used to prevent and treat respiratory distress syndrome in newborns. Specifically it is used in those who are born premature. It is given in the trachea. Effects begin within minutes and may last for up to 3 days.

Common side effects include slow heart rate, low oxygen, low blood pressure, high blood pressure, apnea, and blockage of the endotracheal tube. Other side effects may include sepsis. It is a pulmonary surfactant derived from cows.

Beractant was approved for medical use in the United States in 1991. In the United States 100 mg costs about 400 USD as of 2022.